Medplus Health Services Ltd (BOM:543427) (Q2 2027) Earnings Call
NiveshIQ
NSE: MEDPLUS · Consumer Services
Medplus Health Services Ltd.
₹596.50▲ ₹16.60 (+2.86%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on MEDPLUS. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Medplus Health Services Ltd.
MedPlus Health Services Limited operates a diversified retail and wholesale network of pharmacies and FMCG stores across India, selling prescription medicines, over‑the‑counter drugs, vitamins, medical devices and diagnostic kits. The company also offers diagnostic, pathological and laboratory testing services, and contracts for private‑label pharmaceutical and FMCG manufacturing. In FY2026, MedPlus generated ₹7,595 crore in revenue and ₹211 crore in net income, with an adjusted EBITDA margin of 4.4%. Recent earnings reports show a 21% revenue growth in Q2 FY2027, though margin pressures have kept profitability modest. The board is set to discuss a share buy‑back in early November, while institutional investors such as ICICI Prudential have increased their stake to 9.21%. MedPlus maintains
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹5,625 Cr +23.42% | ₹6,136 Cr +9.09% | ₹6,892 Cr +12.33% |
| EBITDA Margin | 6.29% | 7.94% | 8.81% |
| Net Profit | ₹65.47 Cr +31.57% | ₹150.32 Cr +129.59% | ₹219.64 Cr +46.12% |
| EPS | ₹5.48 | ₹12.57 | ₹18.33 |
Annual figures in Indian Rupees (Crores). Source: company filings (NSE).
Recent News
Medplus Health Services Ltd (BOM:543427) (Q2 2027) Earnings Call Highlights: Margin Expansion, ...
MedPlus Health Services board to meet Nov 6 to consider share buy-back
🔒
+ 3 more stories about Medplus Health Services Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q2FY27 results: revenue ₹2, 037 Cr, PAT ₹56 Cr, EPS ₹4.73, EBITDA margin 8.3%. Growth context: revenue YoY +21.3%, PAT YoY +1.0%, revenue QoQ +8.4%, PAT QoQ +69.0%.
Management commentary points to product launches, approvals, and therapy-mix improvement as the primary near-term growth...
FY26 (last completed FY): revenue ₹6, 892 Cr, PAT ₹220 Cr, EBITDA margin 8.8%, EPS ₹18.33. Year-on-year: revenue YoY +12...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantMore Consumer Services stocks
Everything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for MEDPLUS
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track MEDPLUS alongside your other holdings
Unlock full MEDPLUS research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Medplus Health Services Ltd.?
NiveshIQ detects active intelligence signals for Medplus Health Services Ltd. (MEDPLUS) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Medplus Health Services Ltd.?
Medplus Health Services Ltd. operates in the Consumer Services sector with a market capitalisation of ₹1,069,964.5L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.